Cytokine, sickness behavior, and depression.
暂无分享,去创建一个
[1] J. Weiss,et al. The subdiaphragmatic vagus nerves mediate activation of locus coeruleus neurons by peripherally administered microbial substances , 2005, Neuroscience.
[2] R. Nelson,et al. Photoperiod alters hypothalamic cytokine gene expression and sickness responses following immune challenge in female Siberian hamsters (Phodopus sungorus) , 2005, Neuroscience.
[3] T. Jhou. Neural mechanisms of freezing and passive aversive behaviors , 2005, The Journal of comparative neurology.
[4] R. Dantzer,et al. Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice , 2005, Journal of Neuroimmunology.
[5] Joseph E LeDoux,et al. Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior , 2005, Neuron.
[6] A. A. Romanovsky,et al. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. , 2005, Frontiers in bioscience : a journal and virtual library.
[7] C. Nemeroff,et al. The neurobiology of depression: inroads to treatment and new drug discovery. , 2005, The Journal of clinical psychiatry.
[8] Jing Chen,et al. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] R. Dantzer,et al. Inactivation of the Cerebral NFκB Pathway Inhibits Interleukin-1β-Induced Sickness Behavior and c-Fos Expression in Various Brain Nuclei , 2005, Neuropsychopharmacology.
[10] R. Dantzer,et al. NFκB Activates in vivo the Synthesis of Inducible Cox-2 in the Brain , 2005 .
[11] A. Ferguson,et al. Prostaglandin E2 Mediates Cellular Effects of Interleukin‐1β on Parvocellular Neurones in the Paraventricular Nucleus of the Hypothalamus , 2005, Journal of neuroendocrinology.
[12] R. Dantzer,et al. Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. , 2005, The Journal of infectious diseases.
[13] I. Bechmann,et al. Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] C. Lyketsos,et al. Mood Disorders in the Medically Ill: Scientific Review and Recommendations , 2005, Biological Psychiatry.
[15] A. Dunn,et al. Physiological and behavioral responses to interleukin-1β and LPS in vagotomized mice , 2005, Physiology & Behavior.
[16] Erik A. Yuill,et al. Interleukin-1β depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non selective cationic conductance , 2005, Regulatory Peptides.
[17] Caroline E. Wright,et al. Acute inflammation and negative mood: Mediation by cytokine activation , 2005, Brain, Behavior, and Immunity.
[18] A. Siegel,et al. Potentiating role of interleukin-1β (IL-1β) and IL-1β type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat , 2005, Brain Research.
[19] A. Kusnecov,et al. Neuronal, Endocrine, and Anorexic Responses to the T-Cell Superantigen Staphylococcal Enterotoxin A: Dependence on Tumor Necrosis Factor-α , 2005, The Journal of Neuroscience.
[20] T. Möller,et al. Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.
[21] D. Simmons,et al. Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[22] George P Chrousos,et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. , 2005, The Journal of clinical endocrinology and metabolism.
[23] B. Winblad,et al. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines , 2005, Brain, Behavior, and Immunity.
[24] Ansuman T. Satpathy,et al. IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes1 , 2005, The Journal of Immunology.
[25] R. Dantzer,et al. The taste of sickness: Lipopolysaccharide-induced finickiness in rats , 2005, Physiology & Behavior.
[26] V. Perry,et al. Differential regulation of type I and type II interleukin‐1 receptors in focal brain inflammation , 2005, The European journal of neuroscience.
[27] A. Kusnecov,et al. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A , 2005, Brain, Behavior, and Immunity.
[28] William A Banks,et al. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.
[29] A. Kusnecov,et al. Neural and behavioral responses to systemic immunologic stimuli: a consideration of bacterial T cell superantigens. , 2005, Current pharmaceutical design.
[30] M. Wichers,et al. Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[31] Xiaoxia Li,et al. Modulation of Toll–interleukin 1 receptor mediated signaling , 2005, Journal of Molecular Medicine.
[32] Andrew H. Miller,et al. Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.
[33] S. Poole,et al. Circulating leptin mediates lipopolysaccharide‐induced anorexia and fever in rats , 2004, The Journal of physiology.
[34] J. Cidlowski,et al. Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.
[35] V. Perry. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.
[36] J. Huston,et al. Extinction-induced immobility in the water maze and its neurochemical concomitants in aged and adult rats: A possible model for depression? , 2004, Neurobiology of Learning and Memory.
[37] B. Wisse,et al. Physiological regulation of hypothalamic IL-1beta gene expression by leptin and glucocorticoids: implications for energy homeostasis. , 2004, American journal of physiology. Endocrinology and metabolism.
[38] J. Wardle,et al. Mild acute inflammatory stimulation induces transient negative mood , 2004, Journal of Psychosomatic Research.
[39] T. Hamazaki,et al. Dietary n-3 fatty acids selectively attenuate LPS-induced behavioral depression in mice , 2004, Physiology & Behavior.
[40] R. Dantzer,et al. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy , 2004, Brain, Behavior, and Immunity.
[41] A. Blomqvist,et al. Rat brain vascular distribution of interleukin‐1 type‐1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli , 2004, The Journal of comparative neurology.
[42] M. Lynch,et al. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[43] R. Nelson,et al. Seasonal immune function and sickness responses. , 2004, Trends in immunology.
[44] Lixia Zhao,et al. Suppression of Proinflammatory Cytokines Interleukin-1β and Tumor Necrosis Factor-α in Astrocytes by a V1 Vasopressin Receptor Agonist: A cAMP Response Element-Binding Protein-Dependent Mechanism , 2004, The Journal of Neuroscience.
[45] F. Marvel,et al. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei , 2004, Brain, Behavior, and Immunity.
[46] R. Dantzer,et al. Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice , 2004, Brain, Behavior, and Immunity.
[47] Rodney W. Johnson,et al. α-Tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice , 2004, Brain, Behavior, and Immunity.
[48] B. Leonard,et al. Dietary Ethyl-eicosapentaenoic Acid but not Soybean Oil Reverses Central Interleukin-1-induced Changes in Behavior, Corticosterone and Immune Response in Rats , 2004, Stress.
[49] G. Asnis,et al. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release , 2004, Behavioural Brain Research.
[50] M. Irwin,et al. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. , 2004, The American journal of psychiatry.
[51] R. Dantzer. Innate immunity at the forefront of psychoneuroimmunology , 2004, Brain, Behavior, and Immunity.
[52] A. Kusnecov,et al. Effects of bacterial superantigens on behavior of mice in the elevated plus maze and light–dark box , 2004, Brain, Behavior, and Immunity.
[53] M. Kavaliers,et al. Comparing immune activation (lipopolysaccharide) and toxin (lithium chloride)-induced gustatory conditioning: lipopolysaccharide produces conditioned taste avoidance but not aversion , 2004, Behavioural Brain Research.
[54] H. Anisman,et al. Neurochemical sensitization associated with systemic administration of tumor necrosis factor-α: adjuvant action in combination with bovine serum albumin , 2003, Journal of Neuroimmunology.
[55] R. Dantzer,et al. Nuclear factor κB nuclear translocation as a crucial marker of brain response to interleukin‐1. A study in rat and interleukin‐1 type I deficient mouse , 2003, Journal of neurochemistry.
[56] C. Nemeroff,et al. Interferon-alpha–induced changes in tryptophan metabolism relationship to depression and paroxetine treatment , 2003, Biological Psychiatry.
[57] S. Maier,et al. Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders. , 2003, Journal of affective disorders.
[58] T. Nishikawa,et al. Distribution of anxiogenic-induced c-Fos in the forebrain regions of developing rats , 2003, Journal of Neural Transmission.
[59] C. Stockmeier. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. , 2003, Journal of psychiatric research.
[60] K. Shirey,et al. Synergistic Transcriptional Activation of Indoleamine Dioxygenase by IFN-γ and Tumor Necrosis Factor-α , 2003 .
[61] M. Kavaliers,et al. Activation of the immune system in rats with lipopolysaccharide reduces voluntary sucrose intake but not intraoral intake , 2003, Pharmacology Biochemistry and Behavior.
[62] J. Kelly,et al. Inhibition of Constitutive Nitric Oxide Production Increases the Severity of Lipopolysaccharide-Induced Sickness Behaviour: A Role for TNF-α , 2003, Neuroimmunomodulation.
[63] S. Rivest,et al. Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response , 2003, The Journal of Neuroscience.
[64] Ruslan Medzhitov,et al. Toll-Like Receptor Signaling Pathways , 2003, Science.
[65] M. Lynch,et al. Activation of p38 Plays a Pivotal Role in the Inhibitory Effect of Lipopolysaccharide and Interleukin-1β on Long Term Potentiation in Rat Dentate Gyrus* , 2003, Journal of Biological Chemistry.
[66] Y. Nomura,et al. Inhibition of leptin-induced IL-1β expression by glucocorticoids in the brain , 2003, Brain Research.
[67] N. Metcalfe,et al. Carotenoid Modulation of Immune Function and Sexual Attractiveness in Zebra Finches , 2003, Science.
[68] B. Faivre,et al. Immune Activation Rapidly Mirrored in a Secondary Sexual Trait , 2003, Science.
[69] D. Tio,et al. Effects of glossopharyngeal nerve transection on central and peripheral cytokines and serum corticosterone induced by localized inflammation , 2003, Journal of Neuroimmunology.
[70] R. Weiss,et al. Cytokine mediation of experimental heart failure-induced anhedonia. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[71] R. Dantzer,et al. Cytokines and depression: The need for a new paradigm , 2003, Brain, Behavior, and Immunity.
[72] N. Quan,et al. Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus , 2003, Brain Research Bulletin.
[73] Colm Cunningham,et al. The impact of systemic infection on the progression of neurodegenerative disease , 2003, Nature Reviews Neuroscience.
[74] H. Anisman,et al. Dissociating anorexia and anhedonia elicited by interleukin-1β: antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake , 2003, Psychopharmacology.
[75] G. Aguilera,et al. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors , 2003, Neuroscience.
[76] H. Anisman,et al. Cytokines as a stressor: implications for depressive illness. , 2002, The international journal of neuropsychopharmacology.
[77] H. Fox,et al. Regulation of Indoleamine 2,3-Dioxygenase Expression in Simian Immunodeficiency Virus-Infected Monkey Brains , 2002, Journal of Virology.
[78] N. Nicolson,et al. Effects of Acute Tryptophan Depletion on Mood and Cortisol Release in First-degree Relatives of Type I and Type II Bipolar Patients and Healthy Matched Controls , 2002, Neuropsychopharmacology.
[79] T. Day,et al. Systemic administration of interleukin‐1β activates select populations of central amygdala afferents , 2002, The Journal of comparative neurology.
[80] R. Dantzer,et al. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen , 2002, Brain, Behavior, and Immunity.
[81] Ronald Glaser,et al. Depression and immune function: central pathways to morbidity and mortality. , 2002, Journal of psychosomatic research.
[82] J. Haddad,et al. Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IκB/NF-κB-sensitive pathway in the alveolar epithelium , 2002 .
[83] H. Anisman,et al. Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes , 2002, Brain, Behavior, and Immunity.
[84] H. Anisman,et al. Murine tumor necrosis factor-α sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine , 2002, Journal of Neuroimmunology.
[85] W. Riedel,et al. Tryptophan, mood, and cognitive function , 2002, Brain, Behavior, and Immunity.
[86] A. Świergiel,et al. Distinct Roles for Cyclooxygenases 1 and 2 in Interleukin-1-Induced Behavioral Changes , 2002, Journal of Pharmacology and Experimental Therapeutics.
[87] A. Dunn,et al. Effects of Interleukin-1β on Food-Maintained Behavior in the Mouse , 2002, Brain, Behavior, and Immunity.
[88] S. Zalcman. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists , 2002, Brain Research.
[89] P. Sawchenko,et al. Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults , 2002, The Journal of Neuroscience.
[90] P. Sawchenko,et al. Involvement of the Arcuate Nucleus of the Hypothalamus in Interleukin-1-Induced Anorexia , 2002, The Journal of Neuroscience.
[91] V. Perry,et al. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease , 2002, Neuroscience.
[92] C. Nemeroff,et al. Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions , 2002, Neuropsychopharmacology.
[93] P. Willner,et al. The validity of animal models of predisposition to depression. , 2002, Behavioural pharmacology.
[94] B. Kudielka,et al. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress , 2002, Journal of Neuroimmunology.
[95] P. Rogers,et al. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. , 2002, Placenta.
[96] E. Sternberg,et al. Anti-Inflammatory Cytokines: Expression and Action in the Brain , 2002, Neuroimmunomodulation.
[97] I. Goshen,et al. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120 , 2002, Brain Research.
[98] R. Nelson,et al. Short day lengths attenuate the symptoms of infection in Siberian hamsters , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[99] R. Dantzer,et al. Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.
[100] H. Anisman,et al. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor‐α: peripheral and central mechanisms , 2002, The European journal of neuroscience.
[101] D. Overstreet,et al. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism , 2002, Psychiatric genetics.
[102] L. Muglia,et al. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. , 2002, American journal of physiology. Endocrinology and metabolism.
[103] N. Kawashima,et al. Effects of staphylococcal enterotoxin A on pituitary–adrenal activation and neophobic behavior in the C57BL/6 mouse , 2002, Journal of Neuroimmunology.
[104] T. Ben-Hur,et al. A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis , 2001, Neuroscience.
[105] A. Świergiel,et al. The Reductions in Sweetened Milk Intake Induced by Interleukin-1 and Endotoxin Are Not Prevented by Chronic Antidepressant Treatment , 2001, Neuroimmunomodulation.
[106] W. Banks,et al. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. , 2001, The Journal of pharmacology and experimental therapeutics.
[107] R. Dantzer,et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy , 2001, Psychoneuroendocrinology.
[108] R. Dantzer,et al. Rat microglial cells secrete predominantly the precursor of interleukin‐1β in response to lipopolysaccharide , 2001, The European journal of neuroscience.
[109] A. Świergiel,et al. Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice , 2001, Pharmacology Biochemistry and Behavior.
[110] H. Meltzer,et al. Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation , 2001, Molecular Psychiatry.
[111] C. Nemeroff,et al. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies , 2001, Biological Psychiatry.
[112] T. Pollmächer,et al. Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.
[113] J. Bol,et al. A single administration of interleukin‐1 or amphetamine induces long‐lasting increases in evoked noradrenaline release in the hypothalamus and sensitization of ACTH and corticosterone responses in rats , 2001, The European journal of neuroscience.
[114] T. Motawi,et al. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. , 2001, The international journal of biochemistry & cell biology.
[115] A. V. D. Does,et al. The effects of tryptophan depletion on mood and psychiatric symptoms. , 2001 .
[116] R. Dantzer,et al. Timing and Specificity of the Cognitive Changes Induced by Interleukin-2 and Interferon-&agr; Treatments in Cancer Patients , 2001, Psychosomatic medicine.
[117] S. Zalcman. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity , 2001, Brain Research.
[118] F. Chiappelli,et al. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity , 2001, Journal of Neuroimmunology.
[119] M. Caligiuri,et al. Social stress increases the susceptibility to endotoxic shock , 2001, Journal of Neuroimmunology.
[120] R. Dantzer. Cytokine-Induced Sickness Behavior: Where Do We Stand? , 2001, Brain, Behavior, and Immunity.
[121] J. Roth,et al. Fever induction pathways: evidence from responses to systemic or local cytokine formation. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[122] M. Maes,et al. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. , 2001, Journal of affective disorders.
[123] R. Dantzer,et al. Dexamethasone up‐regulates type II IL‐1 receptor in mouse primary activated astrocytes , 2001, Journal of neurochemistry.
[124] N. Craddock,et al. Candidate gene studies of bipolar disorder , 2001, Annals of medicine.
[125] S. Maier,et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats , 2000, Autonomic Neuroscience.
[126] A. A. Romanovsky,et al. Thermoregulatory manifestations of systemic inflammation: lessons from vagotomy , 2000, Autonomic Neuroscience.
[127] R. Dantzer,et al. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? , 2000, Autonomic Neuroscience.
[128] R. Dantzer,et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats , 2000, Autonomic Neuroscience.
[129] S. Maier,et al. Vagal immune-to-brain communication: a visceral chemosensory pathway , 2000, Autonomic Neuroscience.
[130] S. Maier,et al. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever , 2000, Autonomic Neuroscience.
[131] A. A. Romanovsky,et al. Multiple neural mechanisms of fever , 2000, Autonomic Neuroscience.
[132] R. Dantzer,et al. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis , 2000, The European journal of neuroscience.
[133] R. Dantzer,et al. Role of interleukin‐1β and tumour necrosis factor‐α in lipopolysaccharide‐induced sickness behaviour: a study with interleukin‐1 type I receptor‐deficient mice , 2000 .
[134] Camellia P. Clark,et al. Clinical and Physiological Consequences of Rapid Tryptophan Depletion , 2000, Neuropsychopharmacology.
[135] R. Dantzer,et al. Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS , 2000, Neuroscience.
[136] J. Bauer,et al. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment , 2000, Psychopharmacology.
[137] P. Neveu,et al. Interleukin 1 receptor accessory protein (IL-1RAcP) is necessary for centrally mediated neuroendocrine and immune responses to IL-1β , 2000, Journal of Neuroimmunology.
[138] M. D. de Baets,et al. Inflammation, depressive symptomtology, and coronary artery disease. , 2000, Psychosomatic medicine.
[139] Richard Bandler,et al. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping , 2000, Brain Research Bulletin.
[140] R. Hirschfeld. Antidepressants in long‐term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors , 2000, Acta psychiatrica Scandinavica. Supplementum.
[141] D. Fuchs,et al. Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. , 2000, Current drug metabolism.
[142] R. Dantzer,et al. Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice , 2000, Physiology & Behavior.
[143] Y. Nomura,et al. Depressive behavior and alterations in receptors for dopamine and 5-hydroxytryptamine in the brain of the senescence accelerated mouse (SAM)-P10. , 2000, Japanese journal of pharmacology.
[144] J. Krueger,et al. Nuclear factor-κB inhibitor peptide inhibits spontaneous and interleukin-1β-induced sleep , 2000 .
[145] Y. Nomura,et al. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[146] R. Dantzer,et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[147] R. Dantzer,et al. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[148] S. Woods,et al. Central nervous system control of food intake , 2000, Nature.
[149] R. Hirschfeld. History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.
[150] S. Maier,et al. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1β protein response to acute stress , 2000, Brain Research.
[151] S. Maier,et al. Effects of vagotomy on serum endotoxin, cytokines, and corticosterone after intraperitoneal lipopolysaccharide. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[152] R. Dantzer,et al. Increased Sensitivity of Prediabetic Nonobese Diabetic Mouse to the Behavioral Effects of IL-1 , 1999, Brain, Behavior, and Immunity.
[153] R. Yirmiya,et al. The Immunobiology of Sexual Behavior Gender Differences in the Suppression of Sexual Activity During Illness , 1999, Pharmacology Biochemistry and Behavior.
[154] J. Kelly,et al. Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment , 1999, Neuroimmunomodulation.
[155] R. Wise,et al. Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats , 1999, Brain Research.
[156] K. Buckwalter,et al. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[157] M. Kavaliers,et al. Differential effects of lipopolysaccharide and cholecystokinin on sucrose intake and palatability. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[158] H. Miyaoka,et al. Depression from interferon therapy in patients with hepatitis C. , 1999, The American journal of psychiatry.
[159] CR Plata-Salamán,et al. Cytokine action in the brain , 1999, Molecular Psychiatry.
[160] A. Loudon,et al. Leptin actions on food intake and body temperature are mediated by IL-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[161] J. Francis,et al. Systemic administration of lipopolysaccharide increases plasma leptin levels , 1999, Endocrine.
[162] A. Kusnecov,et al. T-Lymphocyte Activation Increases Hypothalamic and Amygdaloid Expression of CRH mRNA and Emotional Reactivity to Novelty , 1999, The Journal of Neuroscience.
[163] A. Ravaud,et al. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. , 1999, New England Journal of Medicine.
[164] S. MohanKumar,et al. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist 1 Preliminary results were presented at the Experimental Biology meeting, Atlanta, GA, USA, 1995. 1 , 1999, Brain Research.
[165] R. Dantzer,et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats , 1999, Psychoneuroendocrinology.
[166] F. Fumagalli,et al. Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[167] S. Maier,et al. Interleukin-1β in Immune Cells of the Abdominal Vagus Nerve: a Link between the Immune and Nervous Systems? , 1999, The Journal of Neuroscience.
[168] R. Dantzer,et al. Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 β and inducible nitric oxide synthase in rat brain , 1999, Neuroscience.
[169] R. Dantzer,et al. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[170] R. Dantzer,et al. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. , 1999, Neuroreport.
[171] R. Dantzer,et al. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice , 1999, Journal of Neuroimmunology.
[172] C. Plata-salamán. Brain mechanisms in cytokine-induced anorexia , 1999, Psychoneuroendocrinology.
[173] A. Basta-Kaim,et al. Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. , 1998, International journal of immunopharmacology.
[174] A. Armario,et al. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6 , 1998, Journal of Neuroimmunology.
[175] E. Alleva,et al. Behavioural characterization of interleukin‐6 overexpressing or deficient mice during agonistic encounters , 1998, The European journal of neuroscience.
[176] R. Dantzer,et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. , 1998, European cytokine network.
[177] D. Nance,et al. Interleukin-2 and -6 induce behavioral-activating effects in mice , 1998, Brain Research.
[178] T. Lundeberg,et al. Activation of Vagal Afferents after Intravenous Injection of Interleukin-1β: Role of Endogenous Prostaglandins , 1998, The Journal of Neuroscience.
[179] K. McIntyre,et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. , 1998, Journal of immunology.
[180] H. Y. Lee,et al. Temporal and spatial patterns of c‐fos mRNA induced by intravenous interleukin‐1: A cascade of non‐neuronal cellular activation at the blood‐brain barrier , 1998, The Journal of comparative neurology.
[181] M. Lyte,et al. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation , 1998, Physiology & Behavior.
[182] W. Langhans,et al. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1β, LPS, and MDP. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[183] S. Jabbur,et al. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice , 1998, Journal of Neuroimmunology.
[184] R. Dantzer,et al. Interleukin-1β-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[185] M. Schultzberg,et al. Effects of Peripheral Administration of LPS on the Expression of Immunoreactive Interleukin‐1α, β, and Receptor Antagonist in Rat Brain , 1998 .
[186] A. Stalder,et al. Transgenic Models to Study the Actions of Cytokines in the Central Nervous System , 1998, Neuroimmunomodulation.
[187] R. Dantzer,et al. In Vivo and in Vitro Evidence for the Involvement of Tumor Necrosis Factor-α in the Induction of Leptin by Lipopolysaccharide. , 1998, Endocrinology.
[188] E. Alleva,et al. Behavioral effects of peripheral interleukin-1 administration in adult CD-1 mice: specific inhibition of the offensive components of intermale agonistic behavior , 1998, Brain Research.
[189] F. Brambilla,et al. Blood levels of cytokines in elderly patients with major depressive disorder , 1998, Acta psychiatrica Scandinavica.
[190] J. Krueger,et al. Vagotomy Blocks the Induction of Interleukin-1β (IL-1β) mRNA in the Brain of Rats in Response to Systemic IL-1β , 1998, The Journal of Neuroscience.
[191] J. Reul,et al. Tumour necrosis factor‐α and interleukin‐2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic–pituitary–adrenocortical axis activity in the rat , 1998, The European journal of neuroscience.
[192] R. Dantzer,et al. Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[193] H. Anisman,et al. An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat , 1998, Neuroscience.
[194] G. Kollias,et al. Exploratory and Displacement Behavior in Transgenic Mice Expressing High Levels of Brain TNF-α , 1998, Physiology & Behavior.
[195] S. Rivest,et al. Effect of Acute Systemic Inflammatory Response and Cytokines on the Transcription of the Genes Encoding Cyclooxygenase Enzymes (COX‐1 and COX‐2) in the Rat Brain , 1998, Journal of neurochemistry.
[196] C. Plata-salamán,et al. Cytokines and anorexia: a brief overview. , 1998, Seminars in oncology.
[197] A. Grossman,et al. Endotoxin Induces Interleukin-1β and Nitric Oxide Synthase mRNA in Rat Hypothalamus and Pituitary , 1998, Neuroendocrinology.
[198] R. Yirmiya,et al. Effects of Interleukin-1 on Sexual Attractivity in a Model of Sickness Behavior , 1997, Physiology & Behavior.
[199] S. Maier,et al. Vagal Paraganglia Bind Biotinylated Interleukin-1 Receptor Antagonist: A Possible Mechanism for Immune-to-Brain Communication , 1997, Brain Research Bulletin.
[200] A. Świergiel,et al. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra) , 1997, Brain Research.
[201] C. Plata-salamán,et al. Interleukin-1 (IL-1) Receptor Type I Mediates Anorexia but not Adipsia Induced by Centrally Administered IL-1β , 1997, Physiology & Behavior.
[202] E. Bosmans,et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.
[203] R. Johnson,et al. Induction of interleukin-1 beta-converting enzyme (ICE) in murine microglia by lipopolysaccharide. , 1997, Brain research. Molecular brain research.
[204] Y. Pollak,et al. Different receptor mechanisms mediate the effects of endotoxin and interleukin-1 on female sexual behavior , 1997, Brain Research.
[205] M. Minami,et al. Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. , 1997, Brain research. Molecular brain research.
[206] S. Rivest,et al. Regulation of the Genes Encoding Interleukin‐6, Its Receptor, and gp130 in the Rat Brain in Response to the Immune Activator Lipopolysaccharide and the Proinflammatory Cytokine Interleukin‐1β , 1997, Journal of neurochemistry.
[207] M. Herkenham,et al. Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[208] R. Dantzer,et al. Differential Effect of Lipopolysaccharide on Food Hoarding Behavior and Food Consumption in Rats , 1997, Brain, Behavior, and Immunity.
[209] R. Dantzer,et al. Cholecystokinin Receptors do not Mediate the Behavioral Effects of Lipopolysaccharide in Mice , 1997, Physiology & Behavior.
[210] R. Faggioni,et al. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. , 1997, The American journal of physiology.
[211] M. Spurlock. Regulation of metabolism and growth during immune challenge: an overview of cytokine function. , 1997, Journal of animal science.
[212] Y. Pollak,et al. Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. , 1997, Neuroimmunomodulation.
[213] R. Dantzer,et al. Differential Effects of Lipopolysaccharide on Pup Retrieving and Nest Building in Lactating Mice , 1997, Brain, Behavior, and Immunity.
[214] C. Saper,et al. Intravenous lipopolysaccharide induces cyclooxygenase 2‐like immunoreactivity in rat brain perivascular microglia and meningeal macrophages , 1997, The Journal of comparative neurology.
[215] M. Kluger,et al. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. , 1997, The American journal of physiology.
[216] R. Dantzer,et al. Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin‐1 on behaviour , 1997, NeuroReport.
[217] J. Petitto,et al. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2 , 1997, Journal of Neuroimmunology.
[218] R. Oishi,et al. Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain , 1997, Brain Research.
[219] D. Ferrari,et al. Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial Endotoxin , 1997, The Journal of experimental medicine.
[220] L. Leon,et al. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. , 1997, The American journal of physiology.
[221] J. Licinio,et al. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[222] Dennis J. Rivet,et al. Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia , 1997, The Journal of experimental medicine.
[223] R. Dantzer,et al. Mechanisms of sickness-induced decreases in food-motivated behavior , 1996, Neuroscience & Biobehavioral Reviews.
[224] C. Plata-salamán,et al. Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats , 1996, Peptides.
[225] R. Dantzer,et al. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. , 1996, Neuroreport.
[226] C. Plata-salamán,et al. In Vivo Regulation of the IL-1β System (Ligand, Receptors I and II, Receptor Accessory Protein, and Receptor Antagonist) and TNF-α mRNAs in Specific Brain Regions , 1996 .
[227] Yasuyoshi Watanabe,et al. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever , 1996, Brain Research.
[228] M. Gabellec,et al. Interleukin-1 receptor accessory protein transcripts in the brain and spleen: kinetics after peripheral administration of bacterial lipopolysaccharide in mice. , 1996, Neuroimmunomodulation.
[229] C. Plata-salamán,et al. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations , 1996, Physiology & Behavior.
[230] R. Dantzer,et al. Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1β converting enzyme in the pituitary and brain of mice , 1996, Journal of Neuroimmunology.
[231] C. D. Jacobson,et al. Distribution of fos‐like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration , 1996, The Journal of comparative neurology.
[232] R. Dantzer,et al. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. , 1996, Neuroreport.
[233] C. Flachskamm,et al. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway , 1996, Neuroscience.
[234] R. Maki,et al. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies , 1996, Journal of Neuroimmunology.
[235] M. Wong,et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation , 1996, Nature Medicine.
[236] C. Saper,et al. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide , 1996, Brain Research.
[237] P. Ricciardi-Castagnoli,et al. Regulation of the Kynurenine Metabolic Pathway by Interferon‐γ in Murine Cloned Macrophages and Microglial Cells , 1996, Journal of neurochemistry.
[238] R. Dantzer,et al. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. , 1996, Brain research. Molecular brain research.
[239] H. D. de Vries,et al. Interleukin‐1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[240] R. Dantzer,et al. Endogenous glucocorticoids down regulate central effects of interleukin-1 β on body temperature and behaviour in mice , 1995, Brain Research.
[241] C. Flachskamm,et al. Intraperitoneal Administration of Bacterial Endotoxin Enhances Noradrenergic Neurotransmission in the Rat Preoptic Area: Relationship with Body Temperature and Hypothalamic‐Pituitary‐Adrenocortical Axis Activity , 1995, The European journal of neuroscience.
[242] R. Dantzer,et al. Stress Downregulates Lipopolysaccharide-Induced Expression of Proinflammatory Cytokines in the Spleen, Pituitary, and Brain of Mice , 1995, Brain, Behavior, and Immunity.
[243] P. Sawchenko,et al. Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.
[244] G. Fillion,et al. Rat interleukin-1 beta binding sites in rat hypothalamus and pituitary gland. , 1995, Neuroendocrinology.
[245] R. Dantzer,et al. Lipopolysaccharide and Interleukin-1 Depress Food-Motivated Behavior in Mice by a Vagal-Mediated Mechanism , 1995, Brain, Behavior, and Immunity.
[246] C. Plata-salamán. Cytokines and feeding suppression: an integrative view from neurologic to molecular levels. , 1995, Nutrition.
[247] S. Maier,et al. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. , 1995, Life sciences.
[248] R. Dantzer,et al. Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1 beta in mice. , 1995, The American journal of physiology.
[249] M. Labow,et al. Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[250] H. Meltzer,et al. Immunoendocrine aspects of major depression , 1995, European Archives of Psychiatry and Clinical Neuroscience.
[251] R. Dantzer,et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. , 1995, The American journal of physiology.
[252] R. Dantzer,et al. Compared effects of cold ambient temperature and cytokines on macronutrient intake in rats , 1995, Physiology & Behavior.
[253] Eric M. Smith,et al. Presence of interleukin-10 transcripts in human pituitary and hypothalamus , 1995, Cellular and Molecular Neurobiology.
[254] P. Müller-Preuss,et al. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[255] J. Bauer,et al. Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study , 1995, Neuroscience.
[256] Manuel Buttini,et al. Peripheral lipopolysaccharide stimulation induces interleukin-1β messenger RNA in rat brain microglial cells , 1995, Neuroscience.
[257] S. Maier,et al. Blockade of cytokine induced conditioned taste aversion by subdiaphragmatic vagotomy: further evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.
[258] D. Nance,et al. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain , 1994, Brain Research Bulletin.
[259] R. Dantzer,et al. Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice , 1994, Psychoneuroendocrinology.
[260] T. Owens,et al. Inflammatory cytokines in the brain: does the CNS shape immune responses? , 1994, Immunology today.
[261] C. Saper,et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[262] R. Dantzer,et al. Expression of type I and type II interleukin-1 receptors in mouse brain. , 1994, Brain research. Molecular brain research.
[263] R. Dantzer,et al. Reduction in food and water intake induced by microinjection of interleukin-1β in the ventromedial hypothalamus of the rat , 1994, Physiology & Behavior.
[264] R. Dantzer,et al. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.
[265] M. Kluger,et al. Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever. , 1994, The American journal of physiology.
[266] M. Kluger,et al. Interleukin-1 beta causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. , 1994, The American journal of physiology.
[267] F. Squadrito,et al. Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor‐induced inhibition of water intake in the rat , 1994, British journal of pharmacology.
[268] P. Sawchenko,et al. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[269] J. Borrell,et al. Corticosteroid regulation of IL-1 receptors in the mouse hippocampus: effects of glucocorticoid treatment, stress, and adrenalectomy. , 1994, Neuroendocrinology.
[270] C. Nemeroff,et al. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.
[271] B. Rabin,et al. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. , 1993, Endocrinology.
[272] G. Fillion,et al. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. , 1993, Neuroendocrinology.
[273] C Cobelli,et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.
[274] B. D. Clark,et al. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. , 1993, Endocrinology.
[275] D. McCarthy,et al. The role of cholecystokinin in interleukin-1-induced anorexia , 1993, Physiology & Behavior.
[276] M. Kluger,et al. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. , 1993, The American journal of physiology.
[277] R. Dantzer,et al. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[278] R. Dantzer,et al. Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist , 1992, Neuroscience Letters.
[279] M. Brouns,et al. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.
[280] M. M. Coelho,et al. Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. , 1992, The American journal of physiology.
[281] R. Ramachandra,et al. Neuro-hormonal host defence in endotoxin shock , 1992, Brain, Behavior, and Immunity.
[282] R. Dantzer,et al. Mechanisms of the Behavioral Effects of Interleukin 1 Role of Prostaglandins and CRF a , 1992, Annals of the New York Academy of Sciences.
[283] R. Dantzer,et al. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat , 1992, Brain Research.
[284] R. Dantzer,et al. Modulation of the behavioural effects of Interleukin‐1 in mice by Nitric Oxide , 1992, Neuroreport.
[285] G. Fillion,et al. Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus , 1991, Neuroscience.
[286] R. Dantzer,et al. Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior , 1991, Brain Research.
[287] R. Dantzer,et al. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins , 1991, Brain Research.
[288] Takashi Yamaguchi,et al. Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus , 1991, Neuroscience Letters.
[289] M. Kluger. Fever: Role of Pyrogens and Cryogens , 1991, Physiological reviews.
[290] E. D. De Souza,et al. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. , 1990, Endocrinology.
[291] L. Crnic,et al. An animal model for the behavioral effects of interferon. , 1990, Behavioral neuroscience.
[292] A. Vander,et al. The effects of psychological stress on plasma interleukin-6 activity in rats , 1990, Physiology & Behavior.
[293] W. Langhans,et al. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake , 1990, Physiology & Behavior.
[294] C. Blatteis. Neuromodulative actions of cytokines. , 1990, The Yale journal of biology and medicine.
[295] T. Okumura,et al. Indomethacin blocks the anorexic action of interleukin-1. , 1989, European journal of pharmacology.
[296] W. Langhans,et al. Verapamil and indomethacin attenuate endotoxin-induced anorexia , 1989, Physiology & Behavior.
[297] A. Arimura,et al. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. , 1989, The American journal of physiology.
[298] C. Dinarello,et al. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. , 1989, The Journal of clinical investigation.
[299] S. Zuckerman,et al. Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.
[300] R. Dantzer,et al. Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity , 1988, Brain Research.
[301] A. Arimura,et al. Identification of a high-affinity receptor for interleukin-1 beta in rat brain. , 1988, Biochemical and biophysical research communications.
[302] B. Hart. Biological basis of the behavior of sick animals , 1988, Neuroscience & Biobehavioral Reviews.
[303] C. Plata-salamán,et al. Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system , 1988, Brain Research.
[304] P. Ghezzi,et al. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[305] A. Tsou,et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[306] H. Besedovsky,et al. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.
[307] C. Dinarello,et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.
[308] R. Post,et al. Increasing effects of repetitive cocaine administration in the rat , 1976, Nature.
[309] R. Wurtman,et al. Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels , 1971, Science.
[310] R. Dantzer,et al. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. , 2005, The Journal of clinical psychiatry.
[311] B. Brew,et al. Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons , 2005, Glia.
[312] Andrew H. Miller,et al. Neuropsychiatric Adverse Effects of Interferon-α , 2005 .
[313] A. Bousseau,et al. Modulation of interleukin-1 and tumor necrosis factor expression by β-adrenergic agonists in mouse ameboid microglial cells , 2004, Experimental Brain Research.
[314] R. Dantzer,et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy , 2002, Molecular Psychiatry.
[315] L. Solberg,et al. Novel animal models of affective disorders. , 2001, Seminars in clinical neuropsychiatry.
[316] H. Besedovsky,et al. The cytokine-HPA axis feed-back circuit , 2000, Zeitschrift für Rheumatologie.
[317] S. Maier,et al. The pain of being sick: implications of immune-to-brain communication for understanding pain. , 2000, Annual review of psychology.
[318] R. Dantzer,et al. Cytokine signals propagate through the brain , 2000, Molecular Psychiatry.
[319] S. Rivest,et al. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. , 2000 .
[320] J. Reul,et al. Inflammation and brain function under basal conditions and during long-term elevation of brain corticotropin-releasing hormone levels. , 1999, Advances in experimental medicine and biology.
[321] Richard M. Kream,et al. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG , 1999, Psychopharmacology.
[322] A. Dunn,et al. Effects of Cytokines on Cerebral Neurotransmission , 1999 .
[323] H. Anisman,et al. Anhedonic and anxiogenic effects of cytokine exposure. , 1999, Advances in experimental medicine and biology.
[324] A. Reichenberg,et al. Cytokines, "depression due to a general medical condition," and antidepressant drugs. , 1999, Advances in experimental medicine and biology.
[325] L. Leon,et al. An antipyretic role for interleukin-10 in LPS fever in mice. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[326] G. Fantuzzi,et al. IL-1β mediates leptin induction during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[327] E. S. Fox,et al. Modulation of lipopolysaccharide-mediated activation in rat Kupffer cells by antioxidants. , 1998, The Journal of laboratory and clinical medicine.
[328] C. Dinarello,et al. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.
[329] W. Farmerie,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Anorectic Effects of the Cytokine, Ciliary Neurotropic Factor, Are Mediated by Hypothalamic Neuropeptide Y: Comparison with Leptin* , 2022 .
[330] S. Cuzzocrea,et al. Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. , 1997, International journal of immunopharmacology.
[331] K. Feingold,et al. Regulation of lipid metabolism by cytokines during host defense. , 1996, Nutrition.
[332] R. Dantzer,et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[333] T. Bártfai,et al. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. , 1993, Brain research.
[334] R. Dantzer,et al. Vasopressin involvement in antipyresis, social communication, and social recognition: a synthesis. , 1992, Critical reviews in neurobiology.
[335] R. Dantzer,et al. Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.
[336] R. Dantzer,et al. Stress and immunity: an integrated view of relationships between the brain and the immune system. , 1989, Life sciences.
[337] S. Gauthier,et al. Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS. , 1981, Advances in experimental medicine and biology.
[338] R. Bolles. Species-specific defense reactions and avoidance learning. , 1970 .